Dynamics of digital ulcers in systemic sclerosis Corrigendum in /10.3892/etm.2020.9127

Bobeică,Carmen; Tatu,Alin  Laurențiu; Crăescu,Mihaela; Gheuca‑Solovăstru,Laura

doi:10.3892/etm.2020.8572

Dynamics of digital ulcers in systemic sclerosis

Corrigendum in: /10.3892/etm.2020.9127

Authors:
- Carmen Bobeică
- Alin Laurențiu Tatu
- Mihaela Crăescu
- Laura Gheuca‑Solovăstru
View Affiliations

Affiliations: Department of Dermato‑Venereology, Doctoral School, University of Medicine and Pharmacy ‘Gr. T. Popa’ Iași, 700115 Iași, Romania, Department of Clinical Dermato‑Venereology, ‘Dunărea de Jos’ University of Galați, Faculty of Medicine and Pharmacy, ReForm UDJ, 800216 Galați, Romania, Department of Morphological and Functional Sciences, ‘Dunărea de Jos’ University of Galați, Faculty of Medicine and Pharmacy, 800216 Galați, Romania, Department of Clinical Dermato‑Venereology, University of Medicine and Pharmacy ‘Gr. T. Popa’, Faculty of Medicine and Pharmacy, 700115 Iași, Romania
Published online on: February 27, 2020 https://doi.org/10.3892/etm.2020.8572
Pages: 61-67
Copyright: © Bobeică et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Systemic sclerosis (SSc) is a collagenosis with insufficiently known etiopathogenesis, characterized by microvasculopathy and excessive fibrosis in the context of an autoimmune disorder. The incompletely elucidated pathogenesis and limited therapeutic options, disabling aspects, skin lesions and pain determine important functional and psychological deficiencies which affect the quality of life. It is imperative to observe and correlate individual clinical and paraclinical data to optimize disease management. A group of 22 patients diagnosed with SSc, hospitalized in a university clinic in Bucharest was included in an observational study. The evolution of digital ulcers was evaluated as an indicator of vasculopathy and their status and dynamics were correlated with clinical elements reflecting the fibrotic aspect of the disease. The present study shows that the Raynaud phenomenon is almost always present during the course of the disease, but its presence is not always associated with digital ulcers. The existing data in the literature show that fibrosis is subsequent to vasculopathy, but this study did not reveal causality between these two aspects of pathogenesis. The presence of microstomia and digital contracture was identified in the presence of digital ulcers, but also in their absence. The etiopathogenic mechanisms with multiple unknown involved factors open the opportunity to investigate many aspects of SSc for optimal aiming of therapeutic interventions.

View Figures

View References

1	Chihara M, Kurita M, Yoshihara Y, Asahina A and Yanaba K: Clinical significance of serum galectin-9 and soluble CD155 levels in patients with systemic sclerosis. J Immunol Res. 2018(9473243)2018.PubMed/NCBI View Article : Google Scholar
2	Cottin V and Brown KK: Interstitial lung disease associated with systemic sclerosis (SSc-ILD). Respir Res. 20(13)2019.PubMed/NCBI View Article : Google Scholar
3	Butt SA, Jeppesen JL, Fuchs C, Mogensen M, Engelhart M, Torp-Pedersen C, Gislason GH, Jacobsen S and Andersson C: Trends in incidence, mortality, and causes of death associated with systemic sclerosis in Denmark between 1995 and 2015: A nationwide cohort study. BMC Rheumatol. 2(36)2018.PubMed/NCBI View Article : Google Scholar
4	Friedrich S, Lüders S, Glimm AM, Werner SG, Schmittat G, Burmester GR, Backhaus M, Riemekasten G and Ohrndorf S: Association between baseline clinical and imaging findings and the development of digital ulcers in patients with systemic sclerosis. Arthritis Res Ther. 21(96)2019.PubMed/NCBI View Article : Google Scholar
5	McFarlane IM, Bhamra MS, Kreps A, Iqbal S, Al-Ani F, Saladini-Aponte C, Grant C, Singh S, Awwal K, Koci K, et al: Gastrointestinal manifestations of systemic sclerosis. Rheumatology (Sunnyvale). 8(235)2018.PubMed/NCBI View Article : Google Scholar
6	Altorok N, Wang Y and Kahaleh B: Endothelial dysfunction in systemic sclerosis. Curr Opin Rheumatol. 26:615–620. 2014.PubMed/NCBI View Article : Google Scholar
7	Liakouli V, Elies J, El-Sherbiny YM, Scarcia M, Grant G, Abignano G, Derrett-Smith EC, Esteves F, Cipriani P, Emery P, et al: Scleroderma fibroblasts suppress angiogenesis via TGF-β/caveolin-1 dependent secretion of pigment epithelium-derived factor. Ann Rheum Dis. 77:431–440. 2018.PubMed/NCBI View Article : Google Scholar
8	Grigore O, Mihailescu AI, Solomon I, Boda D and Caruntu C: Role of stress in modulation of skin neurogenic inflammation. Exp Ther Med. 17:997–1003. 2019.PubMed/NCBI View Article : Google Scholar
9	Ilie MA, Caruntu C, Lixandru D, Tampa M, Georgescu SR, Constantin MM, Constantin C, Neagu M, Zurac SA and Boda D: In vivo confocal laser scanning microscopy imaging of skin inflammation: Clinical applications and research directions. Exp Ther Med. 17:1004–1011. 2019.PubMed/NCBI View Article : Google Scholar
10	Ilie MA, Caruntu C, Tampa M, Georgescu SR, Matei C, Negrei C, Ion RM, Constantin C, Neagu M and Boda D: Capsaicin: Physicochemical properties, cutaneous reactions and potential applications in painful and inflammatory conditions. Exp Ther Med. 18:916–925. 2019.PubMed/NCBI View Article : Google Scholar
11	Ghiţă MA, Căruntu C, Rosca AE, Căruntu A, Moraru L, Constantin C, Neagu M and Boda D: Real-time investigation of skin blood flow changes induced by topical capsaicin. Acta Dermatovenerol Croat. 25:223–227. 2017.PubMed/NCBI
12	Manetti M, Pratesi S, Romano E, Rosa I, Bruni C, Bellando-Randone S, Guiducci S, Maggi E, Ibba-Manneschi L and Matucci-Cerinic M: Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis. Ann Rheum Dis. 78:575–577. 2019.PubMed/NCBI View Article : Google Scholar
13	Tatu AL and Nwabudike LC: The treatment options of male genital lichen sclerosus et atrophicus: Treatments of genital lichen sclerosus. In: 14th National Congress of Urogynecology (Urogyn), Eforie, Romania, 262-264, 2017.
14	Tatu AL and Ionescu MA: Multiple autoimmune syndrome type III-thyroiditis, vitiligo and alopecia areata. Acta Endocrinol (Bucharest). 13:124–125. 2017.PubMed/NCBI View Article : Google Scholar
15	Kahaleh MB: Raynaud phenomenon and the vascular disease in scleroderma. Curr Opin Rheumatol. 16:718–722. 2004.PubMed/NCBI View Article : Google Scholar
16	Denton CP: Advances in pathogenesis and treatment of systemic sclerosis. Clin Med (Lond). 15 (Suppl 6):s58–s63. 2015.PubMed/NCBI View Article : Google Scholar
17	Codullo V, Distler O and Montecucco C: Pathophysiology of systemic sclerosis. In: Novel Insights into Systemic Sclerosis Management. Publisher Future Medicine Ltd., London, pp22-35, 2013.
18	Nwabudike LC and Tatu AL: Magistral prescription with silver nitrate and Peru Balsam in difficult to heal diabetic foot ulcers. Am J Ther. 25:e679–e680. 2018.PubMed/NCBI View Article : Google Scholar
19	Guillevin L, Hunsche E, Denton CP, Krieg T, Schwierin B, Rosenberg D and Matucci-Cerinic M: DUO Registry Group. Functional impairment of systemic scleroderma patients with digital ulcerations: Results from the DUO Registry. Clin Exp Rheumatol. 31 (Suppl 76):71–80. 2013.PubMed/NCBI
20	Gheorghe I, Tatu AL, Lupu I, Thamer O, Cotar AI, Pircalabioru GG, Popa M, Cristea VC, Lazar V and Chifiriuc MC: Molecular characterization of virulence and resistance features in Staphylococcus aureus clinical strains isolated from cutaneous lesions in patients with drug adverse reactions. Rom Biotechnol Lett. 22:12321–12327. 2017.
21	Ilie MA, Caruntu C, Lupu M, Lixandru D, Tampa M, Georgescu SR, Bastian A, Constantin C, Neagu M, Zurac SA, et al: Current and future applications of confocal laser scanning microscopy imaging in skin oncology. Oncol Lett. 17:4102–4111. 2019.PubMed/NCBI View Article : Google Scholar
22	Herrick A and Muir L: Raynaud's phenomenon (secondary). BMJ Clin Evid: pii: 1125, 2014.
23	Cutolo M, Sulli A, Pizzorni C and Accardo S: Nailfold videocapillaroscopy assessment of microvascular damage in systemic sclerosis. J Rheumatol. 27:155–160. 2000.PubMed/NCBI
24	Tatu AL and Cristea VC: Pityriasis folliculorum of the back thoracic area: Pityrosporum, keratin plugs, or demodex involved? J Cutan Med Surg. 21(441)2017.PubMed/NCBI View Article : Google Scholar
25	Nwabudike LC and Tatu AL: Response to - Chronic exposure to tetracyclines and subsequent diagnosis for non-melanoma skin cancer in a large Mid-Western US population. J Eur Acad Dermatol Venereol. 32(e 159)2018.PubMed/NCBI View Article : Google Scholar
26	Tatu AL and Cristea VC: Unilateral blepharitis with fine follicular scaling. J Cutan Med Surg. 21(442)2017.PubMed/NCBI View Article : Google Scholar
27	Tatu AL and Nwabudike LC: Reply to: Kubiak K et al: Endosymbiosis and its significance in dermatology. J Eur Acad Dermatol Venereol. 32:e346–e347. 2018.PubMed/NCBI View Article : Google Scholar
28	Tatu AL, Clatici VG and Nwabudike LC: Rosacea-like demodicosis (but not primary demodicosis) and papulopustular rosacea may be two phenotypes of the same disease - a microbioma, therapeutic and diagnostic tools perspective. J Eur Acad Dermatol Venereol. 33:e46–e47. 2019.PubMed/NCBI View Article : Google Scholar
29	Tatu AL, Ionescu MA and Nwabudike LC: Contact allergy to topical mometasone furoate confirmed by rechallenge and patch test. Am J Ther. 25:e497–e498. 2018.PubMed/NCBI View Article : Google Scholar
30	Tatu AL, Ciobotaru OR, Miulescu M, Buzia OD, Elisei AM, Mardare N, Diaconu C, Robu S and Nwabudike LC: Hydrochlorothiazide: Chemical structure, therapeutic, phototoxic and carcinogenetic effects in dermatology. Rev Chim (Bucharest). 69:2110–2114. 2018.
31	Nwabudike LC, Elisei AM, Buzia OD, Miulescu M and Tatu AL: Statins. A review on structural perspectives, adverse reactions and relations with non-melanoma skin cancer. Rev Chim (Bucharest). 69:2557–2562. 2018.
32	Tatu AL, Elisei AM, Chioncel V, Miulescu M and Nwabudike LC: Immunologic adverse reactions of β-blockers and the skin (Review). Exp Ther Med. 18:955–959. 2019.PubMed/NCBI View Article : Google Scholar
33	Nwabudike LC, Miulescu M and Tatu AL: Case series of an alternative therapy for generalised lichen planus: Four case studies. Exp Ther Med. 18:943–948. 2019.PubMed/NCBI View Article : Google Scholar
34	Ciobotaru OR, Lupu MN, Rebegea L, Ciobotaru OC, Duca OM, Tatu AL, Voinescu CD, Stoleriu G, Earar K and Miulescu M: Dexamethasone - chemical structure and mechanisms of action in prophylaxis of postoperative side effects. Rev Chim Buchar. 70:843–847. 2019.
35	Kanno Y, Shu E, Kanoh H and Seishima M: The antifibrotic effect of α2AP neutralization in systemic sclerosis dermal fibroblasts and mouse models of systemic sclerosis. J Invest. 136:762–769. 2016.PubMed/NCBI View Article : Google Scholar
36	Vikse J, Gøransson LG and Norheim KB: Systemic capillary leak syndrome following bosentan treatment in a patient with systemic sclerosis. Scand J Rheumatol. 48:426–427. 2019.PubMed/NCBI View Article : Google Scholar
37	Bobeică C, Crăescu M, Ancuța CI, Coman M and Nechita A: Experimental models for the study of systemic scleroderma In: Annals of the University ‘Dunarea de Jos’ of Galati, Fascicle XVII. Galati University Press. 71–84. 2018.
38	Bobeică C, Vâță D, Stătescu L, Țăranu T, Popescu IA, Grăjdeanu AI and Gheucă-Solovăstru L: The quality of life for a patient with an autoimmune disease. Bull Integr Psychiatry. XXV:27–36. 2019.